Bloomberg.com opens with the following.
"March 18 (Bloomberg) -- An adverse jury decision in Alaska may be the first step in tripling to more than $3 billion Eli Lilly & Co.'s costs of resolving lawsuits over Zyprexa, which generates more than one-fourth of the company's revenue."
It seems Eli Lilly was remiss in warning of Diabetes risk related to its Zyprexa.
3 Billion dollars? Can you imagine what $3 Billion - even in neat stacks of brand new banded $100 bills would look like?
If you scroll down the page right here, two posts ago, you'll have no trouble imagining what tardive dyskinesia looks like.
No comments:
Post a Comment